一个cuproptosis纳米囊用于癌症放射治疗
You Liao1,2, Dongmei Wang1,2, Chenglu Gu1,2
1CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.
Nature nanotechnology
|September 19, 2024
概括
向cuproptosis克服了瘤中的辐射抵抗. 这种新的策略使用铜纳米囊来增强放射治疗,从而显著减少瘤和免疫激活.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 纳米医学是一种纳米医学.
背景情况:
- 放射治疗后的残留瘤往往会发展出获得的抗辐射性,阻碍治疗的有效性并导致复发.
- 杯亡的调节者FDX1和LIAS在残留瘤中被上调,这表明它们在抗辐射方面发挥了作用.
研究的目的:
- 研究cuproptosis作为一种新的放射敏感化策略.
- 开发和评估一个含铜的纳米囊,用于辐射触发的cuproptosis.
主要方法:
- 利用患者和小鼠样本在残留瘤中识别上调的质灭调节剂 (FDX1,LIAS).
- 开发并测试了一种装有铜的聚氧甲酸盐纳米囊,在照射时释放铜离子.
- 在临床前模型中评估了辐射触发性cuproptosis在克服放射电阻和诱导abscopal效应方面的有效性.
主要成果:
- 含有铜的纳米囊在暴露于电离辐射时显示出受控的铜离子释放.
- 辐射触发的cuproptosis在临床剂量时有效地克服了获得的辐射耐药性.
- 在抗辐射和再辐射瘤模型中达到40%的治愈率,具有显著的腹腔效应.
结论:
- 向cuproptosis是一个有前途的策略,以打击获得的电阻.
- 这种方法增强了放射治疗的局部抗瘤作用,并刺激了全身抗瘤免疫力.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...


